Showing results (271-280 of 745) with videos related to
Sort By:
Pageof 75
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 6, 2003
Low serum beta-carotene reflects immune activation in patients with coronary artery diseaseL Jonasson, A Wikby, A G OlssonInternational Journal of Behavioral Medicine|August 9, 2005
Good self-rated health is related to psychosocial resources and a strong cortisol response to acute stress: the LiVicordia study of middle-aged menMargareta Kristenson, Anders G Olsson, Zita KucinskieneJournal of Internal Medicine|June 1, 1990
The effect of serum lipid regulation on the development of femoral atherosclerosis in hyperlipidaemia: a non-randomized controlled studyA G Olsson, G Ruhn, U EriksonAtherosclerosis|April 1, 1977
On the rise in low density and high density lipoproteins in response to the treatment of hypertriglyceridaemias in type IV and type V hyperlipoproteinaemiasL A Carlson, G Olsson, D BallantyneCurrent Opinion in Lipidology|December 1, 1995
Trials of lipid-lowering therapy in secondary prevention of coronary heart diseaseA G Olsson, T Pedersen, B BergdahlActa Medica Scandinavica|January 1, 1988
Responsiveness to diving reflex after acute myocardial infarction. Influence of early beta-adrenoceptor blocker therapyG Olsson, N Rehnqvist, A M EkmanThe American Journal of Gastroenterology|April 1, 1990
Liver involvement in Addison's diseaseR G Olsson, A Lindgren, L ZettergrenActa Medica Scandinavica|January 1, 1976
The effects of different dose regimens of niceritrol of serum lipid concentrations in manS Rössner, A G Olsson, L OröAtherosclerosis|July 1, 1975
Dose-response effect of single and combined clofibrate (Atromidin) and niceritrol (Perycit) treatment on serum lipids and lipoproteins in type II hyperlipoproteinaemiaA G Olsson, L Orö, S RössnerCardiovascular Drug Reviews|December 14, 2002
Rosuvastatin: a highly effective new HMG-CoA reductase inhibitorAnders G Olsson, Fergus McTaggart, Ali RazaPageof 75